Modification of HIV-1 (Human immunodeficiency virus type one) Chinese epidemic strain CRF01_AE env gene
A gene and modified technology, applied in plant gene improvement, gene therapy, genetic engineering, etc., can solve urgent problems such as AIDS vaccine research
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0018] 1. Cloning of HIV-1 CRF01_AE env Gene and Acquisition of Consensus Sequence
[0019] For the peripheral venous blood of 100 HIV-1 infected patients in Beijing collected in EDTA anticoagulant blood collection tubes, QIAamp DNA Blood Mini Kit (Cat. No. 51106) from QIAGEN was used to extract proviral DNA according to the instructions. Store at -20°C. The gag gene fragment was amplified by the nested-PCR method, and used for sample HIV-1 type analysis. Using Ex Taq (Cat.No.DRR100A) produced by TaKaRa Company, Gag F2 (5'ATG GGT GCG AGA GCG TCA RTA TTA A 3', HXB2 position 790-814), Gag e2 (5'TCC AAC AGC CCT TTT TCC TAG G 3', HXB2 position 2032~2011) as the outer primer for the first round of PCR reaction, the reaction system is 25μl system: 10×Ex Taq Buffer 2.5μl, 25mM dNTP Mixture 2μl, TaKaRa Ex Taq (5U / μl) 0.125 μl, template 2μl, primers GagF2 and Gag e2 each 0.5μl, add ddH 2 0 to 25 μl. Reaction program: 94°C for 5 minutes, 52°C for 1 minute, 72°C for 2 minutes and 30...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com